Building the business case for continuous manufacturing in biologics, a strategic framework for assessing, comparing, and justifying continuous bioprocessing investments

Authors

• Richard Steiner, Pharmatech Associates, CanadaFollow
• Clifford Rossi, PhD. Professor-of-the-Practice & Executive-in-Residence at the Robert H. Smith School of Business, University of Maryland

Conference Dates

October 5-9, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Richard Steiner and Clifford Rossi, "Building the business case for continuous manufacturing in biologics, a strategic framework for assessing, comparing, and justifying continuous bioprocessing investments" in "Integrated Continuous Biomanufacturing VII (ICB VII)", Irina Ramos, AstraZeneca; Mark Brower, Merck; Alois Jungbauer, BOKU; K. Brower, Sanofi Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/biomanufact_vii/8